Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Sterfte door ebola neemt af bij behandeling met REGN-EB3 en mAb114
aug 2022 | Virale infecties